Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

HUCOP Clinical Pharmacy Rounds: L-Glutamine Use in Sickle Cell Disease

Date: Jun 4, 2019 12:00 PM - 01:00 PM



CE Hours


CE Units


Registration closes on Jun 15, 2019 10:30 PM

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists
  • Students
  • Fellows
  • Residents
  • Faculty


Accreditation Council for Pharmacy Education
Accreditation Statement: Howard University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Joint Provider(s)

Howard University Hospital - Pharmacy Department



Registration Closed  


  • Describe the pathophysiologyof sickle cell disease, its genotypic/phenotypic expression, complications and its prevalence in the United States
  • List current non-pharmacological and pharmacological treatment modalities
  • Outline L-Glutamine as a new FDA approved treatment for sickle cell disease, its safety, efficacy and administration
  • Explain the place in therapy of L-Glutamine in current treatment guidelines and its implications


Dr. Akosu Owusu-Dommey, PharmD
PGY-1 Resident

Activity Number

Date: 06/04/19
Time: 12:00 PM - 01:00 PM

CE Hours

Registration Closed